OpenSpecimen – 2021 Annual Update
We ended 2021 on a high note with many new customers on board from across the world – USA, Netherlands, Singapore, Australia, etc. The best part is that we won …
biobank
State of the Art Biorepository Inaugurated at Hyderabad-based LVPEI
A state-of-the-art Ophthalmic Research Biorepository, to store collections of human tissue for future research on disease mechanisms, therapeutics, and diagnostics, was thrown-open at L V Prasad Eye Institute (LVPEI) campus. …
Biobanking as a Newsletter – Oct 2021
After a tough couple of years, the world is limping back to normalcy. The pandemic is not over, but this festive season certainly feels more cheerful than the last. In …
Thyroid Cancer Registry at University of Nebraska
Thyroid cancer (TC) is the most common endocrine-related malignancy. It is projected that by 2030, it will become the fourth leading cancer diagnosis. Several known risk factors for TC include …
Biobanking as a Newsletter – April 2021
Here is your monthly curated pick of biobanking news, jobs, and events from across the globe. We hope you will find this enriching and useful. Please do let us know your …
Need for the development of the microbiome biobanking infrastructure
The microbiome research field is rapidly evolving, but the required biobanking infrastructure is currently fragmented and not prepared for the biobanking of microbiomes. The rapid advancement of technologies requires an …
Grant launches Dog Aging Project biobank at Cornell
The Cornell Veterinary Biobank has received a $2.5 million federal grant to process, store and distribute biological samples for the Dog Aging Project, a massive national effort to study aging in dogs …
Rapid establishment of a COVID-19 perinatal biorepository
The establishment of a COVID-19 biorepository of specimens from the maternal-neonatal dyad is a critical first step to answering questions about the impact of COVID-19 infection on the pregnant patient …
Possible consequences of the COVID-19 pandemic on the use of biospecimens from cancer biobanks
The COVID-19 pandemic highlights the risks associated with the collection and processing of human biospecimens with an unknown status for the coronavirus SARS-CoV-2, whether for diagnostic, therapeutic, or research purposes. …